281 related articles for article (PubMed ID: 17923111)
21. Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells.
Saatian B; Zhao Y; He D; Georas SN; Watkins T; Spannhake EW; Natarajan V
Biochem J; 2006 Feb; 393(Pt 3):657-68. PubMed ID: 16197369
[TBL] [Abstract][Full Text] [Related]
22. Specific LPA receptor subtype mediation of LPA-induced hypertrophy of cardiac myocytes and involvement of Akt and NFkappaB signal pathways.
Chen J; Chen Y; Zhu W; Han Y; Han B; Xu R; Deng L; Cai Y; Cong X; Yang Y; Hu S; Chen X
J Cell Biochem; 2008 Apr; 103(6):1718-31. PubMed ID: 17891781
[TBL] [Abstract][Full Text] [Related]
23. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq.
Kim J; Keys JR; Eckhart AD
Cell Signal; 2006 Oct; 18(10):1695-701. PubMed ID: 16504475
[TBL] [Abstract][Full Text] [Related]
24. Lysophosphatidic acid acts on LPA
Chabowski DS; Kadlec AO; Ait-Aissa K; Hockenberry JC; Pearson PJ; Beyer AM; Gutterman DD
Br J Pharmacol; 2018 Nov; 175(22):4266-4280. PubMed ID: 30153326
[TBL] [Abstract][Full Text] [Related]
25. Cross-talk between lysophosphatidic acid receptor 1 and tropomyosin receptor kinase A promotes lung epithelial cell migration.
Nan L; Wei J; Jacko AM; Culley MK; Zhao J; Natarajan V; Ma H; Zhao Y
Biochim Biophys Acta; 2016 Feb; 1863(2):229-35. PubMed ID: 26597701
[TBL] [Abstract][Full Text] [Related]
26. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
[TBL] [Abstract][Full Text] [Related]
27. LPA modulates monocyte migration directly and via LPA-stimulated endothelial cells.
Gustin C; Van Steenbrugge M; Raes M
Am J Physiol Cell Physiol; 2008 Oct; 295(4):C905-14. PubMed ID: 18632732
[TBL] [Abstract][Full Text] [Related]
28. Lysophosphatidic acid receptor 2/3-mediated IL-8-dependent angiogenesis in cervical cancer cells.
Chen RJ; Chen SU; Chou CH; Lin MC
Int J Cancer; 2012 Aug; 131(4):789-802. PubMed ID: 21964883
[TBL] [Abstract][Full Text] [Related]
29. Roles of endothelial cells in the regulation of cell motility via lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
Exp Mol Pathol; 2021 Feb; 118():104596. PubMed ID: 33347862
[TBL] [Abstract][Full Text] [Related]
30. LPA
Wang F; Liu S; Pei J; Cai L; Liu N; Liang T; Dong X; Cong X; Chun J; Chen J; Hu S; Chen X
Theranostics; 2020; 10(24):10892-10907. PubMed ID: 33042260
[No Abstract] [Full Text] [Related]
31. LPA
Dancs PT; Ruisanchez É; Balogh A; Panta CR; Miklós Z; Nüsing RM; Aoki J; Chun J; Offermanns S; Tigyi G; Benyó Z
FASEB J; 2017 Apr; 31(4):1547-1555. PubMed ID: 28069828
[TBL] [Abstract][Full Text] [Related]
32. Lysophospholipids increase ICAM-1 expression in HUVEC through a Gi- and NF-kappaB-dependent mechanism.
Lee H; Lin CI; Liao JJ; Lee YW; Yang HY; Lee CY; Hsu HY; Wu HL
Am J Physiol Cell Physiol; 2004 Dec; 287(6):C1657-66. PubMed ID: 15294853
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: relevance to prostate cancer and benign hyperplasia.
Zeng Y; Kakehi Y; Nouh MA; Tsunemori H; Sugimoto M; Wu XX
Prostate; 2009 Feb; 69(3):283-92. PubMed ID: 19025891
[TBL] [Abstract][Full Text] [Related]
34. Lysophosphatidic acid induces vasodilation mediated by LPA1 receptors, phospholipase C, and endothelial nitric oxide synthase.
Ruisanchez É; Dancs P; Kerék M; Németh T; Faragó B; Balogh A; Patil R; Jennings BL; Liliom K; Malik KU; Smrcka AV; Tigyi G; Benyó Z
FASEB J; 2014 Feb; 28(2):880-90. PubMed ID: 24249637
[TBL] [Abstract][Full Text] [Related]
35. Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer.
Liao Y; Mu G; Zhang L; Zhou W; Zhang J; Yu H
Dig Dis Sci; 2013 Dec; 58(12):3524-33. PubMed ID: 24061591
[TBL] [Abstract][Full Text] [Related]
36. Lysophosphatidic acid-induced vascular neointimal formation in mouse carotid arteries is mediated by the matricellular protein CCN1/Cyr61.
Hao F; Zhang F; Wu DD; An D; Shi J; Li G; Xu X; Cui MZ
Am J Physiol Cell Physiol; 2016 Dec; 311(6):C975-C984. PubMed ID: 27760754
[TBL] [Abstract][Full Text] [Related]
37. Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.
Yamada T; Sato K; Komachi M; Malchinkhuu E; Tobo M; Kimura T; Kuwabara A; Yanagita Y; Ikeya T; Tanahashi Y; Ogawa T; Ohwada S; Morishita Y; Ohta H; Im DS; Tamoto K; Tomura H; Okajima F
J Biol Chem; 2004 Feb; 279(8):6595-605. PubMed ID: 14660630
[TBL] [Abstract][Full Text] [Related]
38. Agonist-induced endocytosis of lysophosphatidic acid-coupled LPA1/EDG-2 receptors via a dynamin2- and Rab5-dependent pathway.
Murph MM; Scaccia LA; Volpicelli LA; Radhakrishna H
J Cell Sci; 2003 May; 116(Pt 10):1969-80. PubMed ID: 12668728
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA1, LPA2, and LPA3.
Alcántara-Hernández R; Hernández-Méndez A; Campos-Martínez GA; Meizoso-Huesca A; García-Sáinz JA
PLoS One; 2015; 10(10):e0140583. PubMed ID: 26473723
[TBL] [Abstract][Full Text] [Related]
40. Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expression.
Chuang YW; Chang WM; Chen KH; Hong CZ; Chang PJ; Hsu HC
PLoS One; 2014; 9(5):e95180. PubMed ID: 24879414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
